Filter by: Subject

Filter by: Subject

Results Per Page:

Sub-Saharan Africa (2)
Susceptibility (2)
Syndromic management (2)
Systematic review (2)
Tigecycline (2)
Treatment failure (2)
Tuberculosis -- Treatment (2)
Tuberculosis control (2)
Tuberculosis transmission (2)
Tuberculosis treatment (2)
Vaccine-induced seropositivity (VISP) (2)
Vaginal dysbiosis (2)
Vaginal microbiota (VMB) (2)
Water reuse -- Research -- South Africa (2)
Whole genome sequencing (2)
XDR-TB (2)
Young adults (2)
Young women (2)
(c.425G>A) Mutation (1)
1,4,7-triazacyclononane (TACN) (1)
13-valent PCV vaccine (PCV13) (1)
16S rRNA sequence (1)
18F-FDG PET/CT (1)
18F-fluorodeoxyglucose (FDG) (1)
23S rRNA mutations (1)
24-loci MIRU-VNTR typing (1)
5-Hydroxy-4′,5′,6,7-tetramethoxyflavone (5-demethyl sinensetin) (1)
960™ (1)
[18F]FDG-PET/CT (1)
Abbott RealTime MTB (1)
Achromobacter (1)
Acid-fast bacilli (AFB) (1)
Acientobacter (1)
Acinetobacter baumannii complex (1)
Acinetobacter baumannii complex (ABC) (1)
Acinetobacter spp. (1)
Acquired drug resistance (1)
Actinomycetes (1)
Actinomycosis -- South Africa (1)
Activated sludge (1)
Activated sludge plant (1)
Activity space (1)
Acute HIV infection (AHI) (1)
Adaptation (1)
Adjunctive host-directed therapy (1)
Adjusted relative risk (aRR) (1)
Adult gonorrhea (1)
Advanced HIV disease (1)
Adverse birth outcomes (1)
Adverse drug effects (1)
Adverse perinatal outcomes (1)
Aerosol particles (1)
African sleeping sickness (1)
African trypanosomiasis -- Pretoria (South Africa) (1)
Agarose (1)
Agriculture (1)
Aids (1)
AIDS (Disease) (1)
AIDS (Disease)--Patients (1)
AIDS vaccines (1)